Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Current development of mTOR inhibitors as anticancer agents — Sandrine Faivre (2006) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Current development of mTOR inhibitors as anticancer agents
Shared by
Guido Guido Kroemer
Current development of mTOR inhibitors as anticancer agents
Article
2006
en
Authors
SF
Sandrine Faivre
Guido Guido Kroemer
ÉR
Éric Raymond
Related publications
Article
2007
Evaluation of HIF-1 inhibitors as anticancer agents
Gregg L. Friedman
Article
2018
Recent Development of Sulfonyl or Sulfonamide Hybrids as Potential Anticancer Agents: A Key Review
K.P. Rakesh
,
Shi‐Meng Wang
,
Jing Leng
,
Ravindar Lekkala
,
Abdullah Mohamed Asiri
,
Hadi M. Marwani
,
Hua‐Li Qin
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Article
2004
Histone deacetylase inhibitors: Understanding a new wave of anticancer agents
Ana Villar‐Garea
,
Manel Esteller
Editorial Material
2014
Immunogenic cell death inducers as anticancer agents
Oliver Kepp
,
Laura Senovilla
,
Guido Guido Kroemer
Letter
2020
Promising anticancer therapy: combination of immune checkpoint inhibitors and molecular-targeted agents
Toshiharu Sakurai
,
Naoshi Nishida
,
Masatoshi Kudo
Discussion(0)
No comments yet. Be the first to comment.